Hologic Inc (HOLX) Dividend History

Company News

• Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment

  The global molecular diagnostics for infectious disease market is poised for growth, driven by advancements in biotechnology and genomics, as well as the impact of multiplex assays on diagnosis and treatment. The report covers dynamic trends, including pathogen evolution, globalization, and climate change impacts, and provides insights on the U.S. Medicare Fee Schedules and global data.

  GlobeNewswire Inc.

  Featured Companies: A ABT BDX BIO BIO.B DHR QDEL QGEN TMO
• Epigenetics Market Anticipated to Achieve 11.8% CAGR

  The global epigenetics market is projected to grow from $4.8 billion in 2024 to $8.5 billion by 2029, driven by factors like rising cancer rates, technological advances, and the trend towards precision medicine.

  GlobeNewswire Inc.

  Featured Companies: BIO BIO.B BMY EXAS GH
• Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

  Private equity firms TPG and Blackstone recently bid to acquire Hologic, a medical technology company, valuing it at over $16 billion. Hologic rejected the initial offer, but the negotiations could resume. Hologic's stock has declined 24% this year due to tariff challenges and weakening demand.

  Benzinga

  Featured Companies: BX
• Wall Street Rockets As Bond Yields Drop, Tesla Hits 3-Month Highs: What's Driving Markets Tuesday?

  U.S. equities posted broad-based gains on Tuesday, driven by a drop in Treasury yields and renewed optimism surrounding trade talks between the U.S. and the European Union. The S&P 500 rose 1.9%, extending May's gains to more than 6%, while technology and small-cap stocks outpaced broader benchmarks.

  Benzinga

  Featured Companies: AZO BX CPRT DECK FICO HEI HEI.A KR OKTA RCL TLT TPG TSLA VRSN WBD XLY
• Immunoassay Analyzers Market Size to Hit USD 10.16 Billion by 2032 | SNS Insider

  The Immunoassay Analyzers Market is projected to grow from $7.55 billion in 2023 to $10.16 billion by 2032, driven by the increasing prevalence of chronic diseases, rising demand for early disease detection, and advancements in immunoassay technology.

  GlobeNewswire Inc.

  Featured Companies: A ABT BDX BIO BIO.B PKI QDEL TMO